(Total Views: 429)
Posted On: 04/02/2021 8:42:06 AM
Post# of 36541
Would have to market/persuade heavily on “total” “long term” benefit.
I may be off base but my chief concern would be finding an underserved demographic that would prefer to enroll in a trial rather than wait for existing Pfizer, moderna, or j&j. Could be difficult sell.
I may be off base but my chief concern would be finding an underserved demographic that would prefer to enroll in a trial rather than wait for existing Pfizer, moderna, or j&j. Could be difficult sell.
(0)
(0)Scroll down for more posts ▼
